PolyPill, One Pill, or No Pill? - Frankly Speaking Ep 209

<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Credits: 0.25 <span style="font-style: italic;">AMA PRA Category 1 Credit</span>™</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> CME/CE Information and Claim Credit: <a href= "https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-184"> https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-209</a></p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Overview: In this episode, we will review a recent publication examining how the polypill might lower atherosclerotic cardiovascular disease (ASCVD) risk in the general population.</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Guest: Alan Ehrlich MD, FAAFP</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Music Credit: Richard Onorato</p>